{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T18:17:49Z","timestamp":1782929869824,"version":"3.54.5"},"reference-count":14,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA138292"],"award-info":[{"award-number":["P30CA138292"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000982","name":"Conquer Cancer Foundation","doi-asserted-by":"publisher","award":["59354"],"award-info":[{"award-number":["59354"]}],"id":[{"id":"10.13039\/100000982","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011621","name":"Winship Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001219","name":"Lymphoma Research Foundation","doi-asserted-by":"publisher","award":["59101"],"award-info":[{"award-number":["59101"]}],"id":[{"id":"10.13039\/100001219","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.clml.2025.05.002","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T14:48:29Z","timestamp":1746715709000},"page":"e638-e648","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Racial and Socioeconomic Disparities in Cutaneous T-Cell Lymphoma Survival: Insights From the National Cancer Database"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3959-3662","authenticated-orcid":false,"given":"Pamela","family":"Allen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2321-1885","authenticated-orcid":false,"given":"Muhammad","family":"Hamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessi","family":"Zhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.clml.2025.05.002_bib0001","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jaad.2012.11.021","article-title":"Racial differences in mycosis fungoides: a retrospective study with a focus on eosinophilia","volume":"68","author":"Zampella","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.clml.2025.05.002_bib0002","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","volume":"110","author":"Olsen","year":"2007","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.clml.2025.05.002_bib0003","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1182\/blood-2007-04-087288","article-title":"Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC cutaneous lymphoma group study of 83 cases","volume":"111","author":"Willemze","year":"2008","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.clml.2025.05.002_bib0004","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s40257-022-00732-w","article-title":"Real-life barriers to diagnosis of early mycosis fungoides: an international expert panel discussion","volume":"24","author":"Hodak","year":"2023","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"10.1016\/j.clml.2025.05.002_bib0005","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/pde.14058","article-title":"Structural racism and its influence on the severity of atopic dermatitis in African American children","volume":"37","author":"Tackett","year":"2020","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clml.2025.05.002_bib0006","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jdin.2021.01.007","article-title":"Hidradenitis suppurativa in patients of color is associated with increased disease severity and healthcare utilization: a retrospective analysis of 2 U.S. cohorts","volume":"3","author":"Kilgour","year":"2021","journal-title":"JAAD International"},{"issue":"4","key":"10.1016\/j.clml.2025.05.002_bib0007","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.anai.2018.12.017","article-title":"The socioeconomics of atopic dermatitis","volume":"122","author":"Chung","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.clml.2025.05.002_bib0008","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.12688\/f1000research.16866.1","article-title":"Carrying out streamlined routine data analyses with reports for observational studies: introduction to a series of generic SAS (\u00ae) macros","volume":"7","author":"Liu","year":"2018","journal-title":"F1000Research"},{"issue":"8","key":"10.1016\/j.clml.2025.05.002_bib0009","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.2105\/AJPH.89.8.1240","article-title":"Twenty-year trends in the reported incidence of mycosis fungoides and associated mortality","volume":"89","author":"Weinstock","year":"1999","journal-title":"Am J Public Health"},{"issue":"3","key":"10.1016\/j.clml.2025.05.002_bib0010","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jaad.2017.04.1137","article-title":"Racial disparity in mycosis fungoides: an analysis of 4495 cases from the US National Cancer Database","volume":"77","author":"Su","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"10.1016\/j.clml.2025.05.002_bib0011","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1001\/jamaoncol.2022.3236","article-title":"Incidence trends of primary cutaneous T-cell lymphoma in the US from 2000 to 2018: a SEER population data analysis","volume":"8","author":"Cai","year":"2022","journal-title":"JAMA Oncol"},{"issue":"8","key":"10.1016\/j.clml.2025.05.002_bib0012","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1080\/10428194.2021.1888376","article-title":"Clinical characteristics and outcomes of black patients with mycosis fungoides and s\u00e9zary syndrome: a subgroup analysis of the phase III MAVORIC trial","volume":"62","author":"Johnson","year":"2021","journal-title":"Leuk Lymphoma"},{"issue":"10094","key":"10.1016\/j.clml.2025.05.002_bib0013","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0140-6736(17)31266-7","article-title":"Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial","volume":"390","author":"Prince","year":"2017","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.clml.2025.05.002_bib0014","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/S1470-2045(18)30379-6","article-title":"Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial","volume":"19","author":"Kim","year":"2018","journal-title":"The Lancet Oncology"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265025001557?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265025001557?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T11:18:51Z","timestamp":1762600731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265025001557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":14,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2152265025001557"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2025.05.002","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Racial and Socioeconomic Disparities in Cutaneous T-Cell Lymphoma Survival: Insights From the National Cancer Database","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2025.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}